Literature DB >> 20299378

Cancer risk in patients hospitalized with polymyalgia rheumatica and giant cell arteritis: a follow-up study in Sweden.

Jianguang Ji1, Xiangdong Liu, Kristina Sundquist, Jan Sundquist, Kari Hemminki.   

Abstract

OBJECTIVES: Studies reporting cancer risk after PMR and GCA are few, but it remains an issue of both concern and controversy. We examined the overall and specific cancer risks among Swedish subjects following hospitalization for these diseases.
METHODS: PMR and GCA patients were identified from the Swedish Hospital Discharge Register and by linking them with the Cancer Registry. Follow-up of patients was carried out from the last hospitalization through year 2006. Standardized incidence ratios (SIRs) were calculated in these patients compared with subjects without the diseases.
RESULTS: A total of 35 918 patients were hospitalized for PMR and GCA during the years 1965-2006; the hospitalization rate increased towards late age. A total of 3941 patients developed subsequent cancer, giving an overall SIR of 1.19; and for cancer diagnosed later than 1 year of follow-up, the SIR was 1.06. A significant excess was noted for skin (squamous cell carcinoma and melanoma), stomach, lung, prostate, kidney, nervous system and endocrine gland tumours, and additionally for non-Hodgkin's lymphoma, myeloma and leukaemia. Decreased risk was noted for endometrial cancer.
CONCLUSIONS: Patients hospitalized for PMR and GCA had a marginally increased risk of cancer, with the highest risk noted for the first year after hospitalization. However, for specific cancers, such as skin cancer and leukaemia, the increases were still significant for patients diagnosed later than 1 year after hospitalization, suggesting that these could be true associations, but the mechanisms remain to be established.

Entities:  

Mesh:

Year:  2010        PMID: 20299378     DOI: 10.1093/rheumatology/keq040

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  22 in total

1.  A paraneoplastic syndrome exacerbated by checkpoint inhibition therapy.

Authors:  Heather Villarreal; Kathryn H Dao
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-12

2.  Association between rheumatic diseases and cancer: results from a clinical practice cohort study.

Authors:  Mattia Bellan; Enrico Boggio; Daniele Sola; Antonello Gibbin; Alessandro Gualerzi; Serena Favretto; Giulia Guaschino; Ramona Bonometti; Roberta Pedrazzoli; Mario Pirisi; Pier Paolo Sainaghi
Journal:  Intern Emerg Med       Date:  2017-02-08       Impact factor: 3.397

3.  Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012.

Authors:  Clement John Michet; Sara J Achenbach; Cynthia S Crowson; Eric L Matteson
Journal:  Semin Arthritis Rheum       Date:  2015-03-03       Impact factor: 5.532

4.  Polymyalgia rheumatica and pulmonary adenocarcinoma: A case report and literature review.

Authors:  Sara Coelho; Helena Magalhães; Jorge Correia; Adriana Magalhães; Patrícia Lourenço
Journal:  Porto Biomed J       Date:  2017-02-22

5.  Malignancy risk in vasculitis.

Authors:  Tanaz A Kermani; Kenneth J Warrington; Shreyasee Amin
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

Review 6.  The diagnosis and treatment of giant cell arteritis.

Authors:  Thomas Ness; Thorsten A Bley; Wolfgang A Schmidt; Peter Lamprecht
Journal:  Dtsch Arztebl Int       Date:  2013-05-24       Impact factor: 5.594

Review 7.  Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-02       Impact factor: 5.346

8.  Polymyalgia Rheumatica and its Association with Cancer.

Authors:  Emily C Pfeifer; Cynthia S Crowson; Brittny T Major; Eric L Matteson
Journal:  Rheumatology (Sunnyvale)       Date:  2015-05-07

9.  Concomitant association of giant cell arteritis and malignancy: a multicenter retrospective case-control study.

Authors:  S Deshayes; E Liozon; N Chanson; K Sacré; T Moulinet; C Blanchard-Delaunay; O Espitia; M Groh; M Versini; T Le Gallou; J-E Kahn; V Grobost; S Humbert; M Samson; R Mourot Cottet; K Mazodier; A Dartevel; J Campagne; A Dumont; B Bienvenu; M Lambert; A Daumas; D Saadoun; A Aouba; H de Boysson
Journal:  Clin Rheumatol       Date:  2019-01-07       Impact factor: 2.980

10.  Incidence of malignancy in Takayasu arteritis in Korea.

Authors:  Jin Kyun Park; In Ah Choi; Eun Young Lee; Yeong Wook Song; Eun Bong Lee
Journal:  Rheumatol Int       Date:  2013-10-29       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.